hidden
hidden

NY Stem Cell Foundation Plays Critical Role In Major New ALS Research

In a breakthrough discovery, Dr. Kevin Eggan, Chief Scientific Officer of The New York Stem Cell Foundation and Principal Faculty Member of the Harvard Stem Cell Institute, has produced human stem cell lines from the cells of patients afflicted with a version of amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease. The work, published in the on-line edition of the journal Science, is a major step toward scientists' belief that stem cell research will eventually make it possible to treat patients suffering from chronic diseases with stem cell-based treatments created from their own cells.

In a breakthrough discovery, Dr. Kevin Eggan, Chief Scientific Officer of The New York Stem Cell Foundation and Principal Faculty Member of the Harvard Stem Cell Institute, has produced human stem cell lines from the cells of patients afflicted with a version of amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease. The work, published in the on-line edition of the journal Science, is a major step toward scientists' belief that stem cell research will eventually make it possible to treat patients suffering from chronic diseases with stem cell-based treatments created from their own cells.

View Full Story